| 1 |
34074111 | Perindopril: a long-term certainty in treating hypertension. | 2021 Spring |
1 |
| 2 |
30825199 | Angiotensin-converting enzyme inhibitors attenuated advanced glycation end products-induced renal tubular hypertrophy via enhancing nitric oxide signaling. | 2019 Aug |
1 |
| 3 |
31578675 | A Review of the Role of Bradykinin and Nitric Oxide in the Cardioprotective Action of Angiotensin-Converting Enzyme Inhibitors: Focus on Perindopril. | 2019 Dec |
1 |
| 4 |
29587164 | Nitric oxide donors for peripheral artery disease. | 2018 Apr |
1 |
| 5 |
26670794 | Association of Polymorphisms in Endothelial Nitric Oxide Synthesis and Renin-Angiotensin-Aldosterone System with Developing of Coronary Artery Disease in Bulgarian Patients. | 2016 Feb |
2 |
| 6 |
27099491 | Novel therapeutic mechanisms determine the effectiveness of lipid-core nanocapsules on melanoma models. | 2016 |
1 |
| 7 |
25700580 | The ACE I/D polymorphism is associated with nitric oxide metabolite and blood pressure levels in healthy Mexican men. | 2015 Apr-Jun |
4 |
| 8 |
26177100 | Association of Angiotensin-Converting Enzyme (ACE) Gene Polymorphism with Inflammation and Cellular Cytotoxicity in Vitiligo Patients. | 2015 |
1 |
| 9 |
26275770 | ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension. | 2015 Aug |
1 |
| 10 |
20015194 | A novel pathway for receptor-mediated post-translational activation of inducible nitric oxide synthase. | 2011 Feb |
1 |
| 11 |
21366648 | Influence of angiotensin-converting enzyme insertion/deletion polymorphism on nitric oxide production in hypertensives and hypercholesterolaemics. | 2011 Apr |
1 |
| 12 |
21448379 | Enalapril improves endothelial function in patients with migraine: A randomized, double-blind, placebo-controlled trial. | 2011 Jan |
1 |
| 13 |
22136292 | The higher exercise intensity and the presence of allele I of ACE gene elicit a higher post-exercise blood pressure reduction and nitric oxide release in elderly women: an experimental study. | 2011 Dec 2 |
3 |
| 14 |
20424953 | Angiotensin-converting enzyme 2: central regulator for cardiovascular function. | 2010 Jun |
1 |
| 15 |
18475311 | Association of urinary N-domain Angiotensin I-converting enzyme with plasma inflammatory markers and endothelial function. | 2008 Jul-Aug |
2 |
| 16 |
18520954 | Risk factor-induced cardiovascular remodeling and the effects of angiotensin-converting enzyme inhibitors. | 2008 Jun |
1 |
| 17 |
19033012 | Long-term treatment with sulfhydryl angiotensin-converting enzyme inhibition reduces carotid intima-media thickening and improves the nitric oxide/oxidative stress pathways in newly diagnosed patients with mild to moderate primary hypertension. | 2008 Dec |
1 |
| 18 |
19079593 | Different effects of angiotensin converting enzyme inhibitors on endothelin-1 and nitric oxide balance in human vascular endothelial cells: evidence of an oxidant-sensitive pathway. | 2008 |
2 |
| 19 |
19337531 | Peripheral artery disease: potential role of ACE-inhibitor therapy. | 2008 |
1 |
| 20 |
17305412 | Perindopril versus angiotensin II receptor blockade in hypertension and coronary artery disease: implications of clinical trials. | 2007 |
1 |
| 21 |
17666194 | Rationale for double renin-angiotensin-aldosterone system blockade. | 2007 Aug 6 |
1 |
| 22 |
17666198 | New opportunities in cardiovascular patient management: a survey of clinical data on the combination of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. | 2007 Aug 6 |
1 |
| 23 |
17868792 | Rationale for combining blockers of the renin-angiotensin system. | 2007 Sep |
1 |
| 24 |
16220025 | Antioxidant and nitric oxide-sparing actions of dihydropyridines and ACE inhibitors differ in human endothelial cells. | 2006 |
1 |
| 25 |
16282523 | Angiotensin I-converting enzyme inhibitors block protein kinase C epsilon by activating bradykinin B1 receptors in human endothelial cells. | 2006 Mar |
1 |
| 26 |
16766855 | Long-term treatment with imidapril but not with nifedipine enhances plasma NOx concentration in patients with essential hypertension. | 2006 Jun |
2 |
| 27 |
16872562 | Tea flavanols inhibit angiotensin-converting enzyme activity and increase nitric oxide production in human endothelial cells. | 2006 Aug |
1 |
| 28 |
16962475 | Increased expression of the renin-angiotensin system and mast cell density but not of angiotensin-converting enzyme II in late stages of human heart failure. | 2006 Sep |
1 |
| 29 |
15874906 | Is angiotensin-II an endogenous pro-inflammatory molecule? | 2005 May |
2 |
| 30 |
15883759 | Rethinking the renin-angiotensin system and its role in cardiovascular regulation. | 2005 Jan |
1 |
| 31 |
16462911 | Glyceryl trinitrate-induced angiotensin-converting enzyme (ACE) inhibition in healthy volunteers is dependent on ACE genotype. | 2005 Dec |
1 |
| 32 |
20527397 | [The influence of tissue and plasma angiotensin converting enzyme inhibitors on haemostasis with respect to experimental and clinical investigations]. | 2005 Oct |
2 |
| 33 |
15238791 | Cough and angioedema from angiotensin-converting enzyme inhibitors: new insights into mechanisms and management. | 2004 Aug |
1 |
| 34 |
15495818 | [Study on relationship between the polymorphism of angiotensin converting enzyme gene and blood stasis syndrome in patients with coronary heart disease]. | 2004 Sep |
1 |
| 35 |
15526242 | The role of the renin-angiotensin-aldosterone system in heart failure. | 2004 Sep |
1 |
| 36 |
15526452 | [Nitric oxide correlation with malondialdehyde and angiotensin-converting enzyme in healthy subjects and patients with thoracic wounds]. | 2004 Sep-Oct |
1 |
| 37 |
15614015 | Antidiabetic mechanisms of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists: beyond the renin-angiotensin system. | 2004 Dec |
1 |
| 38 |
12687832 | Angiotensin-converting enzyme and endothelial nitric oxide synthase polymorphisms in patients with atrial fibrillation. | 2003 Jan |
1 |
| 39 |
12818733 | Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular disease. | 2003 Jun 19 |
1 |
| 40 |
12862295 | Modulating atherosclerosis through inhibition or blockade of angiotensin. | 2003 Jul |
1 |
| 41 |
11973410 | Severity of hypertension affects improved resistance artery endothelial function by angiotensin-converting enzyme inhibition. | 2002 May |
1 |
| 42 |
11992135 | Cardioprotective effects of vasopeptidase inhibitors. | 2002 Apr |
2 |
| 43 |
12015245 | High prevalence of polymorphisms of angiotensin-converting enzyme (I/D) and endothelial nitric oxide synthase (Glu298Asp) in patients with systemic sclerosis. | 2002 May |
2 |
| 44 |
12090908 | Pathophysiologic and therapeutic importance of tissue ACE: a consensus report. | 2002 Mar |
2 |
| 45 |
12374901 | PERindopril-Function of the Endothelium in Coronary Artery Disease Trial: the PERFECT study--sub study of EUROPA: rationale and design. | 2002 May |
1 |
| 46 |
12398965 | Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X. | 2002 Nov 1 |
2 |
| 47 |
11158990 | Upregulation of angiotensin-converting enzyme by vascular endothelial growth factor. | 2001 Feb |
1 |
| 48 |
11171786 | Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase. | 2001 Feb 13 |
1 |
| 49 |
11260405 | Renal vascular responses to captopril and to candesartan in patients with type 1 diabetes mellitus. | 2001 Apr |
1 |
| 50 |
11392475 | Vascular protective effects of angiotensin converting enzyme inhibitors and their relation to clinical events. | 2001 Apr |
1 |